Advertisement

Topics

Latest "Drug Development Technology" News Stories

00:13 EDT 24th October 2017 | BioPortfolio

Here are the most relevant search results for "Drug Development Technology" found in our extensive news archives from over 250 global news sources.

More Information about Drug Development Technology on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Drug Development Technology for you to read. Along with our medical data and news we also list Drug Development Technology Clinical Trials, which are updated daily. BioPortfolio also has a large database of Drug Development Technology Companies for you to search.

Showing "Drug Development Technology" News Articles 1–25 of 44,000+

Relevant

UK and Canada Link in Antibacterial Drug Project

LifeArc, the UK medical research charity previously known as MRC Technology, is to collaborate with the government’s Defence Science and Technology Laboratory (Dstl) and Canada’s Centre for Drug Research and Development (CDRD) to identify new antibacterial drug targets.


Cancer Research Technology: Driving Cancer Drug Development

In this programme Fintan Walton talks to Dr Keith Blundy, CEO of Cancer Research Technology, the drug development and commercialisation arm of Cancer Research UK. Having described the relationship between Cancer Research UK and CRT, Dr Blundy goes on to explain that CRT’s role goes beyond drug discovery to source, develop and commercialise drugs in order to achieve their ultimate aim of increasi...

DARTS Technology Launches New Drug Target Identification Service Designed To Streamline Drug Development

  Life Sciences Jobs   ...


Science Says: Gene Editing Widely Used in Range of Research

NewsGene editing is getting fresh attention thanks to a successful lab experiment with human embryos. Despite angst over possibly altering reproduction years from now, the technology already is used by scientists in fields ranging from agriculture to drug development.

DARTS Technology Launches New Drug Target Identification Service Designed to Streamline Drug Development

Enables Identification of Potential Side Effects Before Trials DARTS Sciences, Inc. (www.dartssciences.com) has obtained an exclusive license for the DARTS patent (Drug Affinity Responsive Target Stability Technology), and is the sole provider of the cutting edge technology designed to streamline drug development and save pharmaceutical and biotech com...

China Joins Pursuit of Global Drug Development Standards

BlogDrug development is a global endeavor, requiring international collaboration to ensure that consistent standards are adopted and adhered to by all drug makers and regulatory authorities, regardless of country of origin or destination.

Drug Development at the Portfolio Level

This Viewpoint discusses the drug development portfolio—a family of trials assessing a drug for different indications or in different combinations with other drugs—and summarizes some of the challenges drug portfolios pose for policy, care, and human protections.

F.I.R.S.T.™ - a platform for effective drug discovery

The strategic value of BioInvent consists of the patented technology platforms F I R S T™ and n-CoDeR®, as well as considerable expertise in pre-clinical and clinical development and the production of antibody-based drugs. This accumulated competence and know-how serve as the basis of revenue generating contract research and in-house strategic drug development. Michael Oredsson, CEO, BioInvent

LifeArc, Dstl, CDRD Partner to Identify Targets for Multidrug Resistant Infections

The U.K.’s LifeArc (previously MRC Technology), Defense Science and Technology Laboratory (Dstl) and Canada’s Centre for Drug Research and Development (CDRD) established a partnership to identify novel antibacterial targets as the foundation for multi-drug resistance (MDR) antibiotic drug discovery and development.programs. The organizations say that while antibacterial drug discovery has ...

LifeArc, Dstl, CDRD Partner to Identify Targets for Multidrug-Resistant Infections

The U.K.’s LifeArc (previously MRC Technology), Defense Science and Technology Laboratory (Dstl) and Canada’s Centre for Drug Research and Development (CDRD) established a partnership to identify novel antibacterial targets as the foundation for multi-drug resistance (MDR) antibiotic drug discovery and development.programs. The organizations say that while antibacterial drug discovery has ...

LifeArc teams up with UK defence lab and Canada’s CDRD

LifeArc, the UK medical research charity previously known as MRC Technology, is working alongside the government’s Defence Science and Technology Laboratory and Canada’s Centre for Drug Research and Development (CDRD) to identify new antibacterial drug targets.

Prous Institute: Speeding up the drug discovery and development process

How much of a pharmaceutical candidate’s efficacy and safety can be predicted in silico, hence significantly speeding up the drug development process? Prous Institute for Biomedical Research is committed to discovering novel therapies for substantially unmet medical needs – namely oncology and CNS - by applying their expertise in computational science, synthetic chemistry, molecular and cellul...

Emory Institute for Drug Development (EIDD): Cutting-edge drug discovery and development programs

The EIDD was founded and constructed to provide the multidisciplinary capabilities that are required to effectively advance cutting-edge drug discovery and development programs at the preclinical stage. Fintan Walton, CEO of PharmaVentures interviews Dennis Liotta, Executive Director Emory Institute for Drug Development, Emory College

Greener Molecular Intermediates May Aid Drug Design

NewsTheir method should make drug design and development cheaper and more environmentally friendly.

Streamlined Process Opens Drug Development to New Class of Steroids

NewsThe core molecular structure of steroids is a proven backbone in drug development.

Drug Development Costs Revisited

A recent paper on drug development costs did not impress me. But if possible, it impressed Matthew Herper at Forbes even less. That’s the one where the authors looked at a number of companies that had been around long enough to develop one drug – they figured that this would give a cleaner read on

Life Sciences Companies Adopt Veeva Systems, Inc. Vault Development Cloud As Their Technology Foundation For Drug Development

  Life Sciences Jobs   ...

Possible Breakthrough in Colorectal Cancer Drug Development Cited

NewsStemSynergy announces breakthrough in colorectal cancer drug development. Scientists showed that a novel class of Wnt inhibitors, CK1alpha agonists, blocked colorectal cancer growth with minimal gastrointestinal toxicity.

Dimerix: Advancing new drug therapies through the clinic for unmet medical needs

Dimerix Limited is a clinical stage, biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB). The Company is focused on developing new therapeutics discovered using its proprietary drug development platform, Receptor-Heteromer Investigation Technology (HIT).

EC Awards Antares Grant to Develop Lyophilized Injectables Inspection Technology

NewsAntares Vision awarded European Commission grant to develop new technology for inspection of lyophilized injectables. The Lyo-Check project will result in development of a fully automated industrial machine for 100 percent inspection of lyophilizes.

Drug antibody firm collaborates on Innovate UK project

Antibody drug company Glythera has been awarded a grant from the government's innovation agency Innovate UK to develop the next generation of biological therapeutics. Glythera won the £248,000 funding as part of a team including bioscience firm GlycoSeLect and the Centre for Process Innovation in Redcar. The early stage feasibility study award will support the growth of drug development pa...

Substance Drug AbusePipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Substance Drug AbusePipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Substance Drug Abuse. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trial...

LifeArc, Dstl & CDRD partner to identify antibacterial drug targets

UK-based LifeArc and Defence Science and Technology Laboratory (Dstl) will collaborate with Canada’s The Centre for Drug Research and Development (CDRD) to identify antibacterial drug targets.

NIST's quick test may speed antibiotic treatment and combat drug resistance

(National Institute of Standards and Technology (NIST)) Researchers at the National Institute of Standards and Technology (NIST) have demonstrated a potential new tactic for rapidly determining whether an antibiotic combats a given infection, thus hastening effective medical treatment and limiting the development of drug-resistant bacteria. Their method can quickly sense mechanical fluctuations of...

Medherant announces new clinical product development lead

Medherant, a University of Warwick spin-out company, developing transdermal drug delivery patch technology, has announced the appointment of Sheryl Caswell as head of clinical development.


Quick Search
Advertisement
 

News Quicklinks